University of Essex
Colchester, Essex, CO4 3SQ, United Kingdom
NCT Number: NCT07538349
This study investigates how the design of weblinks in digital vaccination invitation emails influences recipient trust and their willingness to book an appointment. In this study, investigators compare three different link formats: a control third-party link previously used by the NHS, and two experimental weblinks: an improved version of the link, and a text embedded hyperlink.
The study tests primarily whether the two experimental weblinks will be perceived as more trustworthy and increase booking intention than the control weblink. Furthermore, the study examined whether the experimental weblinks are perceived to be more fluent (easier to read) and improve participants' ability to correctly identify the organisation (e.g., the NHS or a US pharmacy) that sent the hypothetical email.
To test these effects, investigators planned to gather data from 2,000 participants from the United Kingdom and 2,000 from the United States. They will be assigned to view one of the three hypothetical email versions. UK participants will see emails that appear to be from the NHS, while US participants see emails that appear to be from a local fictitious pharmacy. Due to US emails appearing to come from a fictitious pharmacy, investigators also expected that the benefit of correctly identifying the host organisation would be more pronounced in the United Kingdom than in the United States.
This research aims to provide evidence on how to design more effective and trustworthy digital health communications.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Colchester, Essex, CO4 3SQ, United Kingdom
This randomised experimental study investigates how weblink design influenced the perceived trustworthiness of digital health communications. As digital invitations (e.g., emails and SMS) have become standard for public health initiatives such as vaccination programmes, the use of third-party or disfluent (hard-to-read) web links may inadvertently undermine trust.
Study Protocol and Intervention
Participants will be randomly allocated to one of three experimental conditions. In all conditions, participants will view a hypothetical email invitation for a COVID-19 booster vaccine. The content of the emails remains identical except for the format of the embedded booking link:
Control Condition: Features the "accurx" web link previously used by the National Health Service (NHS) in the UK.
Experimental Condition 1: Features an improved, transparent - "clear" - weblink that was designed to be easier to read and clearly identifies the host organisation (e.g., https://vaccine-booking.nhs.uk).
Experimental Condition 2: Features a text-embedded hyperlink.
To ensure relevance to the target populations, the stimuli are tailored to participants' countries of residence: UK participants see invitations appearing to come from the NHS, while US participants see slightly different versions of the email appearing to be sent by their local fictitious pharmacy. Unlike the UK, COVID-19 vaccination in the US was predominantly organised by local pharmacies.
Primary Hypotheses
The study is designed to test five primary hypotheses:
Measurement
Following the presentation of the stimulus, participants will rate the email on three 5-point Likert scales: trustworthiness (1: Very suspicious to 5: Very trustworthy), fluency (1: Very difficult to 5: Very easy), and booking intention (1: Very unlikely to 5: Very likely). Host identification is assessed via a multiple-choice question with four options: "the NHS", "your local pharmacy", "accurx", or "Not sure".
Investigators will gather data from 2,000 participants from the UK and 2,000 from the US. They will be invited to complete the study via an online platform. Participants who complete the study too fast or fail the attention check will be excluded.
This study will be conducted as part of a larger research project exploring the broader relationship between the content of health text messages and trust perception.
The study hypotheses, design, measures and analyses were preregistered before the start of data collection on a different platform (AsPredicted). This time stamped preregistration protocol is linked as a document in this registration.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants were presented a hypothetical COVID-19 booster vaccination invitation email that included a booking weblink. The intervention involved improving the weblink included in the email to make it easier to read and facilitate the identification of the website host.
Participants were presented a hypothetical COVID-19 booster vaccination invitation email that included a booking weblink. The intervention involved concealing the weblink included in the email within text using a hyperlink (click HERE).
Time frame: Immediately after the intervention
Participants rated the perceived trustworthiness of the vaccination invitation email on a 5-point Likert scale, where 1 represents "Very suspicious", and 5 represents "Very trustworthy".
Time frame: Immediately after the intervention
Participants rated their likelihood of booking a vaccine appointment based on the email invitation using a 5-point Likert scale ranging from 1 ("Very unlikely") to 5 ("Very likely").
Time frame: Immediately after the intervention
Participants assessed the reading ease or fluency of the embedded weblink on a 5-point Likert scale, where 1 is "Very difficult", and 5 is "Very easy".
Time frame: Immediately after the intervention
Participants were asked to identify the organisation that sent the communication by selecting one answer from a multiple-choice list of four options: the NHS, your local pharmacy, Accurx, or Unclear/I don't know
University of Essex
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03587610
Vaccination
Le Mans, France
View Trial DetailsNCT01054053
Vaccination
Neufchâtel-en-Bray, France
View Trial DetailsNCT07007377
Flu, Flu-like Symptoms
São Paulo, Brazil
View Trial DetailsNCT04936776
Hematologic Diseases, Hemic and Lymphatic Diseases
New York, United States
View Trial Details